KarXT (Karuna Therapeutics) met its primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia, the company has announced. KarXT is an oral coformulation of ...

Add Yahoo as a preferred source to see more of our stories on Google. Katie Melua recently opened up about suffering an acute psychotic breakdown in her 20s. (Getty Images) Being there for a loved one ...

The investigational combination xanomeline-trospium (KarXT) was effective and well tolerated in individuals with schizophrenia who were experiencing acute psychosis, according to the randomized ...

A mom was in tears earlier this week as she learned her 12-year-old daughter, who died in a psychiatric unit in England last year, was suffering from a rare but possibly treatable brain disorder that ...

The EMERGENT-3 trial, published in the Journal of the American Medical Association Psychiatry, represents a significant advancement in the treatment of schizophrenia, particularly for individuals ...

Khan, S. and Issa, H. (2026) Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis. Open Journal of Psychiatry, 16, 131-138. doi: 10.4236/ojpsych.2026.162010 .

This week, a hearing at a coroner's court determined the child was suffering from a rare but possibly treatable brain disorder that spurred her behavior After hearing the new evidence, Mia's mom wiped ...